Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -100,217 | -66,317 | -37,735 | -13,075 | -45,593 |
| Depreciation Amortization | 8,204 | 5,879 | 3,548 | 1,764 | 3,334 |
| Accounts receivable | 577 | 577 | -327 | -279 | -577 |
| Accounts payable and accrued liabilities | 54 | 1,082 | 4,005 | 4,150 | 990 |
| Other Working Capital | -61,923 | -46,468 | -28,045 | -14,684 | 124,867 |
| Other Operating Activity | 24,359 | 14,653 | 5,220 | -699 | 5,109 |
| Operating Cash Flow | $-128,946 | $-90,594 | $-53,334 | $-22,823 | $88,130 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,597 | -1,096 | -790 | -164 | -9,096 |
| Purchase Of Investment | -456,404 | -292,006 | -46,164 | -16,013 | -529,382 |
| Sale Of Investment | 358,166 | 261,286 | 152,000 | 60,500 | 115,890 |
| Investing Cash Flow | $-99,835 | $-31,816 | $105,046 | $44,323 | $-422,588 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -849 | -693 | -341 | -155 | -554 |
| Common Stock Issued | 251,526 | 248,919 | 2,925 | 1,147 | 196,835 |
| Other Financing Activity | -397 | 0 | -397 | -397 | 92,981 |
| Financing Cash Flow | $250,280 | $248,226 | $2,187 | $595 | $289,262 |
| Beginning Cash Position | 32,593 | 32,593 | 32,593 | 32,593 | 77,789 |
| End Cash Position | 54,092 | 158,409 | 86,492 | 54,688 | 32,593 |
| Net Cash Flow | $21,499 | $125,816 | $53,899 | $22,095 | $-45,196 |
| Free Cash Flow | |||||
| Operating Cash Flow | -128,946 | -90,594 | -53,334 | -22,823 | 88,130 |
| Capital Expenditure | -1,597 | -1,096 | -790 | -164 | -9,096 |
| Free Cash Flow | -130,543 | -91,690 | -54,124 | -22,987 | 79,034 |